What Is Histopathology?

Expertise, specialities, and training

Histology is the study of tissues, and pathology is the study of disease. So taken together, histopathology means the study of tissues related to disease.

A histopathology report describes the tissue that the pathologist examined. It also identifies features of what cancer looks like under the microscope. A histopathology report is also called a biopsy report or a pathology report.

This article explains what is in a histopathology report and how to interpret results.

female doctor looking in microscope
Hero Images / Getty Images

How Is Histopathology Performed?

A specialist doctor who examines tissue under a microscope is called a pathologist. Pathologists study biopsied tissue in a lab.

Pathologists process and cut tissue into very thin layers (called sections). Then, they stain and examine it under a microscope. Under a microscope, they can observe and document the tissue's cell details.

Frozen Section

For some diseases, the surgeon can get a sample of the tissue interpreted very quickly through frozen sections (also called a cryosection). Frozen sections are emergency procedures in the lab and usually require a result within about 20 minutes.

This type of pathology is most commonly used to evaluate tumor margins to determine if a surgeon needs to remove more tissue.

However, frozen sections or slices are used sparingly in lymphoma due to problems in interpretation and sampling.

Lymph and Blood Cancers

Lymph nodes are the tissue most commonly examined to evaluate lymphomas in histopathology. A bone marrow biopsy may also be required for a definitive diagnosis for many types of blood cancers.​

Components of a Histopathology Report

Histopathology reports on surgical cancer specimens can be complex. They may include:

  • The appearance of the involved tissue
  • Diagnosis
  • Synoptic report detailing the findings of the case
  • Pathologist's comments

Histopathology reports can be challenging to understand, so it's essential to go over them with a healthcare provider. Understanding the components of the report ahead of time may help you prepare for your appointment.

Interpreting the Results

Many of the pathologist's findings inform prognosis.


Prognosis is the prediction or estimate of survival or recovery from a disease.

Prognostic indicators may include:

  • Tumor grade
  • Extent of spread
  • Evidence of healthy cells around the cancer
  • Evidence cancer has spread

Grading systems differ depending on the kind of cancer. However, the cells are generally scored based on how abnormal they appear under the microscope.

For example, Grade 1 tumors appear more normal, whereas Grade 4 tumors reflect more abnormalities. In other words, the higher the grade, the higher the abnormalities.

Grading is not the same as staging. Staging has more to do with where the cancer is found in the body and how far it has spread.

Other Sampling Techniques

In addition to histopathology, pathologists may use other techniques to assess the presence of cancer in the tissues.

Molecular Techniques

Molecular techniques refer to the ability to analyze cells and tissues at the molecular level, which is at the level of proteins, receptors, and genes.

Pathologists diagnose leukemias and lymphomas through a combination of techniques, including:

  • Cytochemistry: How cells in the bone marrow take up certain stains
  • Immunophenotype: Looks for unique surface proteins
  • Karyotype: Chromosomal changes
  • Morphology: How the cells look


Often in lymphomas and other cancers, doctors use immunohistochemistry to help assess the tumor type, prognosis, and treatment.

What Is Immunohistochemistry?

Immunohistochemistry involves using antibodies to stick to particular tags or markers outside the cancer cells. These markers that the antibodies attach to often have "CD" in their name, which stands for "cluster of differentiation." CDs identify cell phenotypes, which, in turn, identify different cancers.

For example, if CD23 and CD5 are present in the cancer cells, it might support the notion that chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) is a possible diagnosis.

However, these same markers are also present in other malignancies. So doctors use a process of elimination based on the available information and what is known about the various malignancies and their "typical" CD markers.

Another example of a CD marker is CD20, which is present in some lymphomas but absent in others. For example, diffuse large B cell lymphoma, or DLBCL, is a very common lymphoma associated with the CD20 marker.

For a given sample of leukemia or lymphoma cells, pathologists can test markers using an entire panel of antibodies that stick to different markers, with built-in positive and negative controls.

Chromosomal Studies

Pathologists may perform molecular and chromosomal studies to look at gene rearrangements and specific changes to the chromosomes. Sometimes inserted or deleted genes inform prognosis.

For instance, in CLL, a specific piece of a chromosome (17p) is lost. Along with the missing chromosome, a gene that helps suppress cancer is often lost. The 17p deletion is found in about 5-10% of people with CLL overall. The 17p deletion CLL is a form of CLL that is harder to treat with conventional chemotherapy.


Doctors may use additional pathology techniques to diagnose cancer. For example, molecular techniques look at proteins, receptors, and genes, which can help identify leukemias and lymphomas. In addition, immunohistochemistry looks for markers on cancer cells to narrow down what type of cancer a person has. Finally, chromosomal studies look at gene differences to develop a prognosis.


Histopathology studies tissue to look for disease. Pathologists perform histopathology in a lab. They examine tissue under a microscope and develop a report of their findings. Histopathology reports include descriptions of the tissue, diagnosis, and prognosis. In addition to evaluating tissue, pathologists may also use other techniques to assess and diagnose cancer.

A Word From Verywell

Histopathology reports can be confusing. That's why it's best not to jump to conclusions before going over them with a healthcare provider. Your report will contain information about your tissue sample, offer a diagnosis or suggestions for further testing, and a prognosis if enough information is available. These details will help a doctor manage your treatment in the future.

Was this page helpful?
7 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. National Cancer Institute. NCI dictionary of cancer terms.

  2. UC Davis Health. Best practices in frozen section analysis.

  3. Taxy JB, Husain AN, Montag AG. Biopsy Interpretation: The Frozen Section. Philadelphia, PA: Lippincott Williams & Wilkins; 2012.

  4. College of American Pathologists. How to read your pathology report.

  5. Schafer KA, Eighmy J, Fikes JD, et al. Use of severity grades to characterize histopathologic changes. Toxicol Pathol. 2018;46(3):256-265. doi:10.1177/0192623318761348

  6. Ho C, Rodig SJ. Immunohistochemical markers in lymphoid malignancies: Protein correlates of molecular alterations. Semin Diagn Pathol. 2015;32(5):381-91. doi:10.1053/j.semdp.2015.02.016

  7. Yu L, Kim HT, Kasar S, et al. Survival of Del17p CLL depends on genomic complexity and somatic mutation. Clin Cancer Res. 2017;23(3):735-745. doi:10.1158/1078-0432.CCR-16-0594

Additional Reading